ANTX
AN2 Therapeutics, Inc.
-0.17 (-3.28%)5.17USD69.4K成交股數195M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.0M | 6.7M | 6.9M | 7.0M | 3.2M | 7.7M | 8.3M | 12.1M | 14.7M | 14.9M | 14.4M | 13.5M |
| 銷售管理費用 | 2.9M | 3.8M | 2.4M | 3.0M | 4.0M | 3.8M | 3.5M | 3.7M | 3.6M | 3.9M | 3.8M | 3.1M |
| 營業利益 | −8.9M+23% | −10.6M-9% | −9.3M-34% | −10.0M-37% | −7.2M-61% | −11.5M-39% | −14.0M-23% | −15.9M-4% | −18.3M | −18.8M | −18.2M | −16.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −8.2M+27% | −10.0M-6% | −8.7M-32% | −9.4M-35% | −6.5M-61% | −10.6M-37% | −12.7M-24% | −14.4M-9% | −16.6M | −16.9M | −16.7M | −15.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.18-14% | -0.29-17% | -0.29-33% | -0.31-35% | -0.21-63% | -0.35-29% | -0.43-34% | -0.48-41% | -0.56 | -0.49 | -0.65 | -0.81 |
| 稀釋股數 | 44.8M | 34.1M | 30.2M | 30.3M | 30.2M | 30.1M | 29.8M | 29.8M | 29.8M | 23.6M | 25.6M | 19.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 44.3M | 53.5M | 19.9M | 18.0M | 18.2M | 20.0M | 33.5M | 26.8M | 24.7M | 15.6M | 32.6M | 40.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 81.7M | 87.5M | 62.0M | 67.2M | 75.8M | 81.3M | 97.7M | 108M | 121M | 139M | 154M | 98.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.8M | 5.7M | 8.9M | 6.9M | 7.0M | 8.0M | 10.0M | 10.1M | 10.7M | 14.0M | 14.8M | 11.2M |
| 股東權益 | 75.9M | 81.8M | 53.1M | 60.4M | 68.8M | 73.3M | 87.7M | 98.4M | 111M | 125M | 139M | 87.8M |
| 負債比 | 7.0% | 6.6% | 14.4% | 10.2% | 9.2% | 9.9% | 10.3% | 9.3% | 8.8% | 10.1% | 9.6% | 11.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.1M+14% | – | – | – | −10.6M | – | – | −17.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −35.2M | –% | -1.16 | – |
| FY2024 | – | – | −51.3M | –% | -1.72 | – |
| FY2023 | – | – | −64.7M | –% | -2.74 | – |
| FY2022 | – | – | −41.0M | –% | -2.79 | – |
| FY2021 | – | – | −21.5M | –% | -10.64 | – |